Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
November 10 2016 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a
corporate update at the Stifel 2016 Healthcare Conference on
Wednesday, November 16th, 2016 at 8:00 a.m. Eastern Time at The
Lotte New York Palace Hotel.
A live webcast of Ironwood’s presentation will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. To access the webcast, please log on to the
Ironwood website approximately 15 minutes prior to the start time
to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial
biotechnology company focused on creating medicines that make a
difference for patients, building value for our fellow
shareholders, and empowering our passionate team. We are advancing
a pipeline of innovative medicines in areas of significant unmet
need, including irritable bowel syndrome with constipation
(IBS-C)/chronic idiopathic constipation (CIC), uncontrolled gout,
refractory gastroesophageal reflux disease, and vascular and
fibrotic diseases. We discovered, developed and are commercializing
linaclotide, the U.S. branded prescription market leader
in the IBS-C/CIC category, and we are applying our proven R&D
and commercial capabilities to advance multiple
internally-developed and externally-accessed product opportunities.
Ironwood was founded in 1998 and is headquartered
in Cambridge, Mass. For more information, please visit
www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161110006483/en/
Ironwood Pharmaceuticals, Inc.Media RelationsTrista Morrison,
617-374-5095Director, Corporate
Communicationstmorrison@ironwoodpharma.comorInvestor
RelationsMeredith Kaya, 617-374-5082Director, Investor
Relationsmkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Sep 2023 to Sep 2024